Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Department of Anesthesiology, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
J Alzheimers Dis. 2019;67(1):137-147. doi: 10.3233/JAD-180858.
Disruption of intracellular Ca2+ homeostasis and associated autophagy dysfunction contribute to neuropathology in Alzheimer's disease (AD).
To study the effects of propofol on cell viability via its effects on intracellular Ca2+ homeostasis, and the impact of autophagy, in a neuronal model of presenilin-mutated familial AD (FAD).
We treated PC12 cells, stably transfected with either mutated presenilin-1 (L286V) or wild type (WT) controls, with propofol at different doses and durations, in the presence or absence of extracellular Ca2+, antagonists of inositol trisphosphate receptors (InsP3R, xestospongin C) and/or ryanodine receptors (RYR, dantrolene), or an inhibitor of autophagy flux (Bafilomycin). We determined cell viability, cytosolic Ca2+ concentrations ([Ca2+]c), vATPase protein expression, and lysosomal acidification.
The propofol dose- and time-dependently decreased cell viability significantly more in L286V than WT cells, especially at the pharmacological dose (>50μM), and together with bafilomycin (40 nM). Clinically used concentrations of propofol (<20μM) tended to increase cell viability. Propofol significantly increased [Ca2+]c more in L286V than in WT cells, which was associated with decrease of vATPase expression and localization to the lysosome. Both toxicity and increased Ca2+ levels were ameliorated by inhibiting InsP3R/RYR. However, the combined inhibition of both receptors paradoxically increased [Ca2+]c, by inducing Ca2+ influx from the extracellular space, causing greater cytotoxicity.
Impairment in autophagy function acts to deteriorate cell death induced by propofol in FAD neuronal cells. Cell death is ameliorated by either RYR or InsP3R antagonists on their own, but not when both are co-administered.
细胞内钙离子稳态的破坏和相关的自噬功能障碍导致阿尔茨海默病(AD)的神经病理学改变。
通过研究丙泊酚对细胞内钙离子稳态的影响及其对自噬的影响,研究其对突变早老素 1(L286V)的 presenilin 家族性 AD(FAD)神经元模型的细胞活力的影响。
我们用不同剂量和时间的丙泊酚处理 PC12 细胞,这些细胞稳定转染了突变的早老素-1(L286V)或野生型(WT)对照物,存在或不存在细胞外 Ca2+、三磷酸肌醇受体(InsP3R,xestospongin C)和/或肌质网 Ca2+ 释放通道(RYR,丹曲林)拮抗剂,或自噬流抑制剂(Bafilomycin)。我们测定细胞活力、胞浆钙离子浓度([Ca2+]c)、vATPase 蛋白表达和溶酶体酸化。
丙泊酚剂量和时间依赖性地显著降低 L286V 细胞的活力,尤其是在药理学剂量(>50μM)下,与 Bafilomycin(40 nM)联合使用时。临床使用的丙泊酚浓度(<20μM)有增加细胞活力的趋势。与 WT 细胞相比,丙泊酚显著增加 L286V 细胞的[Ca2+]c,这与 vATPase 表达的减少和向溶酶体的定位有关。抑制 InsP3R/RYR 可改善毒性和增加的 Ca2+水平。然而,两种受体的联合抑制反而通过诱导细胞外 Ca2+内流而增加[Ca2+]c,从而导致更大的细胞毒性。
自噬功能的损害会加重 FAD 神经元细胞中丙泊酚诱导的细胞死亡。单独使用 RYR 或 InsP3R 拮抗剂可改善细胞死亡,但两者同时使用则无效。